Literature DB >> 9683987

Risperidone-induced photosensitivity.

D S Almond1, L E Rhodes, M Pirmohamed.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9683987      PMCID： PMC2360853          DOI： 10.1136/pgmj.74.870.252

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  6 in total

1.  The dermatologic and systemic manifestations of chlorpromazine hypersensitivity; their clinical significance and management.

Authors:  F J AYD
Journal:  J Nerv Ment Dis       Date:  1956-07       Impact factor: 2.254

Review 2.  Cutaneous photosensitivity diseases induced by exogenous agents.

Authors:  J W Gould; M G Mercurio; C A Elmets
Journal:  J Am Acad Dermatol       Date:  1995-10       Impact factor: 11.527

3.  Chlorpromazine photosensitivity. Phototoxic and photoallergic reactions.

Authors:  S Epstein
Journal:  Arch Dermatol       Date:  1968-10

4.  A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.

Authors:  G Chouinard; B Jones; G Remington; D Bloom; D Addington; G W MacEwan; A Labelle; L Beauclair; W Arnott
Journal:  J Clin Psychopharmacol       Date:  1993-02       Impact factor: 3.153

5.  Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations.

Authors:  O J Høyberg; C Fensbo; J Remvig; O Lingjaerde; M Sloth-Nielsen; I Salvesen
Journal:  Acta Psychiatr Scand       Date:  1993-12       Impact factor: 6.392

Review 6.  Adverse effects of antipsychotic agents. Do newer agents offer advantages?

Authors:  D G Owens
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.